A MicroRNA expression profile defining the invasive bladder tumor phenotype

Urologic Oncology: Seminars and Original Investigations

Volumn 29, Issue 6, 2011, Pages 794-801.e1

  Wszolek, Matthew F ^a   Rieger Christ, Kimberly M ^a   Kenney, Patrick A ^a   Gould, Justin J ^a   Silva Neto, Brasil ^a,c   LaVoie, Amanda K ^a   Logvinenko, Tanya ^b   Libertino, John A ^a   Summerhayes, Ian C ^a  

^a LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Bladder cancer; Invasion; MicroRNA

Indexed keywords

MICRORNA; MICRORNA 141; MICRORNA 200A; MICRORNA 200B; MICRORNA 200C; MICRORNA 205; MICRORNA 21; MICRORNA 222; MICRORNA 30B; MICRORNA 31; MICRORNA 99A; UNCLASSIFIED DRUG;

ARTICLE; BLADDER CARCINOMA; BLADDER TRANSITIONAL CELL CARCINOMA; CANCER CELL CULTURE; CANCER INVASION; CANCER SURVIVAL; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; INVASIVE CARCINOMA; MICROARRAY ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TRANSITIONAL CELL CARCINOMA;

EID: 81055133663     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2009.08.024     Document Type: Article

References (32)

1. Kent O.A., Mendell J.T. A small piece in the cancer puzzle: MicroRNAs as tumor suppressors and oncogenes. Oncogene 2006, 25:6188-6196.
2. Esquela-Kerscher A., Slack F.J. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 2006, 6:259-269.
3. Calin G.A., Croce C.M. MicroRNA signatures in human cancers. Nat Rev Cancer 2006, 6:857-866.
4. Kusenda B., Mraz M., Mayer J., et al. MicroRNA biogenesis, functionality, and cancer relevance. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2006, 150:205-215.
5. Johnson C.D., Esquela-Kerscher A., Stefani G., et al. The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res 2007, 67:7713-7722.
6. Porkka K.P., Pfeiffer M.J., Waltering K.K., et al. MicroRNA expression profiling in prostate cancer. Cancer Res 2007, 67:6130-6135.
7. Iorio M.V., Ferracin M., Liu C.G., et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005, 65:7065-7070.
8. Lu J., Getz G., Miska E.A., et al. MicroRNA expression profiles classify human cancers. Nature 2005, 435:834-838.
9. Yanaihara N., Caplen N., Bowman E., et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006, 9:189-198.
10. Volinia S., Calin G.A., Liu C.G., et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006, 103:2257-2261.
11. Bloomston M., Frankel W.L., Petrocca F., et al. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 2007, 297:1901-1908.
12. Roldo C., Missiaglia E., Hagan J.P., et al. MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J Clin Oncol 2006, 24:4677-4684.
13. Elsamman E., Fukumori T., Ewis A.A., et al. Differences in gene expression between noninvasive and invasive transitional cell carcinoma of the human bladder using complementary deoxyribonucleic acid microarray: Preliminary results. Urol Oncol 2006, 24:109-115.
14. Ma L., Teruya-Feldstein J., Weinberg R.A. Tumor invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 2007, 449:682-688.
15. Wu W., Sun M., Zou G.M., et al. MicroRNA and cancer: Current status and prospective. Int J Cancer 2007, 120:953-960.
16. Nelson K.M., Weiss G.J. MicroRNAs and cancer: Past, present, and potential future. Mol cancer Therapeut 2008, 7. 3655c60.
17. Neely L.A., Rieger-Christ K.M., Neto B.S., et al. A microRNA expression ratio defining the invasive phenotype in bladder tumors. Urol Oncol 2010, 28:39-48.
18. Korpal M., Lee E.S., Hu G., et al. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem 2008, 283:14910-14914.
19. Hurteau G.J., Carlson J.A., Spivack S.D., et al. Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin. Cancer Res 2007, 67:7972-7976.
20. Huang Q., Gumireddy K., Schrier M., et al. The microRNAs miR-373 and miR-520c promote tumor invasion and metastasis. Nature Cell Biol 2008, 10:202-210.
21. Park S.M., Gaur A.B., Lengyel E., et al. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 2008, 22:894-907.
22. Gregory P.A., Bert A.G., Paterson E.L., et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 2008, 10:593-601.
23. Burk U., Schubert J., Wellner U., et al. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep 2008, 9:582-589.
24. Peltier H.J., Latham G.J. Normalization of microRNA expression levels in quantitative RT-PCR assays: Identification of suitable reference RNA targets in normal and cancerous human solid tissues. RNA (NY) 2008, 14:844-852.
25. Baumgart E., Cohen M.S., Silva Neto B., et al. Identification and prognostic significance of an epithelial-mesenchymal transition expression profile in human bladder tumors. Clin Cancer Res 2007, 13:1685-1694.
26. Bas A., Forsberg G., Hammarstrom S., et al. Utility of the housekeeping genes 18S rRNA, β-actin and glyceraldehyde-3-phosphate-dehydrogenase for normalization in real-time quantitative reverse transcriptase-polymerase chain reaction analysis of gene expression in human T lymphocytes. Scand J Immunol 2004, 59:566-573.
27. Tricarico C., Pinzani P., Bianchi S., et al. Quantitative real-time reverse transcription polymerase chain reaction: Normalization to rRNA or single housekeeping genes is inappropriate for human tissue biopsies. Anal Biochem 2002, 309:293-300.
28. He H., Jazdzewski K., Li W., et al. The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci USA 2005, 102:19075-19080.
29. Miller T.E., Ghoshal K., Ramaswamy B., et al. MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1. J Biol Chem 2008, 283:29897-29903.
30. Veerla S., Lindgren D., Kvist A., et al. MiRNA expression in urothelial carcinomas: Important roles of miR-10a, miR-222, miR-125b, miR-7, and miR-452 for tumor stage and metastasis, and frequent homozygous losses of miR-31. Int J Cancer 2009, 124:2236-2242.
31. Schepeler T., Reinert J.T., Ostenfeld M.S., et al. Diagnostic and prognostic microRNAs in stage II colon cancer. Cancer Res 2008, 68:6416-6424.
32. Zhu S., Si M.L., Wu H., et al. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 2007, 282:14328-14336.